Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus

Abstract Osteoporosis represents a prevalent and debilitating comorbidity in patients diagnosed with type 2 diabetes mellitus (T2DM), which is characterized by suppressed osteoblast function and disrupted bone microarchitecture. In this study, we utilized male C57BL/6 J mice to investigate the role...

Full description

Saved in:
Bibliographic Details
Main Authors: Yansi Xian, Bin Liu, Tao Shen, Lin Yang, Rui Peng, Hongdou Shen, Xueying An, Yutian Wang, Yu Ben, Qing Jiang, Baosheng Guo
Format: Article
Language:English
Published: Nature Publishing Group 2025-03-01
Series:Bone Research
Online Access:https://doi.org/10.1038/s41413-024-00399-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761910749134848
author Yansi Xian
Bin Liu
Tao Shen
Lin Yang
Rui Peng
Hongdou Shen
Xueying An
Yutian Wang
Yu Ben
Qing Jiang
Baosheng Guo
author_facet Yansi Xian
Bin Liu
Tao Shen
Lin Yang
Rui Peng
Hongdou Shen
Xueying An
Yutian Wang
Yu Ben
Qing Jiang
Baosheng Guo
author_sort Yansi Xian
collection DOAJ
description Abstract Osteoporosis represents a prevalent and debilitating comorbidity in patients diagnosed with type 2 diabetes mellitus (T2DM), which is characterized by suppressed osteoblast function and disrupted bone microarchitecture. In this study, we utilized male C57BL/6 J mice to investigate the role of SIRT3 in T2DM. Decreased SIRT3 expression and impaired mitochondrial quality control mechanism are observed in both in vitro and in vivo models of T2DM. Mechanistically, SIRT3 suppression results in hyperacetylation of FOXO3, hindering the activation of the PINK1/PRKN mediated mitophagy pathway and resulting in accumulation of dysfunctional mitochondria. Genetical overexpression or pharmacological activation of SIRT3 restores deacetylation status of FOXO3, thus facilitating mitophagy and ameliorating osteogenic impairment in T2DM. Collectively, our findings highlight the fundamental regulatory function of SIRT3 in mitochondrial quality control, crucial for maintaining bone homeostasis in T2DM. These insights not only enhance our understanding of the molecular mechanisms underlying diabetic osteoporosis but also identify SIRT3 as a promising therapeutic target for diabetic osteoporosis.
format Article
id doaj-art-c9ca80fff9314c8c9704a5aecb36d126
institution DOAJ
issn 2095-6231
language English
publishDate 2025-03-01
publisher Nature Publishing Group
record_format Article
series Bone Research
spelling doaj-art-c9ca80fff9314c8c9704a5aecb36d1262025-08-20T03:05:52ZengNature Publishing GroupBone Research2095-62312025-03-0113111610.1038/s41413-024-00399-5Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitusYansi Xian0Bin Liu1Tao Shen2Lin Yang3Rui Peng4Hongdou Shen5Xueying An6Yutian Wang7Yu Ben8Qing Jiang9Baosheng Guo10Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDivision of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing UniversityAbstract Osteoporosis represents a prevalent and debilitating comorbidity in patients diagnosed with type 2 diabetes mellitus (T2DM), which is characterized by suppressed osteoblast function and disrupted bone microarchitecture. In this study, we utilized male C57BL/6 J mice to investigate the role of SIRT3 in T2DM. Decreased SIRT3 expression and impaired mitochondrial quality control mechanism are observed in both in vitro and in vivo models of T2DM. Mechanistically, SIRT3 suppression results in hyperacetylation of FOXO3, hindering the activation of the PINK1/PRKN mediated mitophagy pathway and resulting in accumulation of dysfunctional mitochondria. Genetical overexpression or pharmacological activation of SIRT3 restores deacetylation status of FOXO3, thus facilitating mitophagy and ameliorating osteogenic impairment in T2DM. Collectively, our findings highlight the fundamental regulatory function of SIRT3 in mitochondrial quality control, crucial for maintaining bone homeostasis in T2DM. These insights not only enhance our understanding of the molecular mechanisms underlying diabetic osteoporosis but also identify SIRT3 as a promising therapeutic target for diabetic osteoporosis.https://doi.org/10.1038/s41413-024-00399-5
spellingShingle Yansi Xian
Bin Liu
Tao Shen
Lin Yang
Rui Peng
Hongdou Shen
Xueying An
Yutian Wang
Yu Ben
Qing Jiang
Baosheng Guo
Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus
Bone Research
title Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus
title_full Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus
title_fullStr Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus
title_full_unstemmed Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus
title_short Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus
title_sort enhanced sirt3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus
url https://doi.org/10.1038/s41413-024-00399-5
work_keys_str_mv AT yansixian enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT binliu enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT taoshen enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT linyang enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT ruipeng enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT hongdoushen enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT xueyingan enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT yutianwang enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT yuben enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT qingjiang enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus
AT baoshengguo enhancedsirt3expressionrestoresmitochondrialqualitycontrolmechanismtoreverseosteogenicimpairmentintype2diabetesmellitus